Will Abbott Stock Keep Surging Behind Emerging Markets?

Abbott Labs'  (NYSE: ABT  ) stock has surged this year, shooting up more than 15% since the start of 2013. Despite the company's spinoff of former pharmaceutical firm AbbVie (NYSE: ABBV  )  -- a move that waved goodbye to its high-growth pharmaceuticals business, including massive immunology blockbuster Humira that pulled in $9 billion in sales last year -- Abbott has still managed to find growth by turning to a new engine: emerging markets.

The company has spread globally, aggressively targeting Brazil in its recent attempt to bid for Ache Labs, one of the country's leading drugmakers. Abbott faces tough competition in the acquisition bid from Pfizer (NYSE: PFE  ) and Novartis (NYSE: NVS  ) , each of which also want to expand their emerging markets push into Brazil's fast-growing health care market, but Abbott has also done a good job growing in China, India, and more. Is this a strategy that will keep Abbott stock growing enough to support your portfolio's future? Fool contributor Dan Carroll and health care analyst Max Macaluso discuss Abbott's recent international push in the video below and how these moves can pay off for the company.

Abbott Labs has changed forever after losing its branded pharmaceutical business to a spinoff. If you're a current investor, or might be buying shares soon, make sure you truly understand the stock by reading The Motley Fool's brand new premium report on Abbott Labs. The report outlines all of the must-know opportunities and risks, along with a full year of analyst updates to keep you up to speed. Best of all, you can claim this report today by clicking here now.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2380433, ~/Articles/ArticleHandler.aspx, 9/26/2016 8:46:44 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 days ago Sponsored by:
DOW 18,261.45 -131.01 0.00%
S&P 500 2,164.69 -12.49 0.00%
NASD 5,305.75 -33.78 0.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/23/2016 4:00 PM
ABT $42.19 Down -0.03 +0.00%
Abbott Laboratorie… CAPS Rating: *****
NVS $81.48 Down -0.55 +0.00%
Novartis CAPS Rating: ****
PFE $34.26 Up +0.11 +0.00%
Pfizer CAPS Rating: ****